Опухоли головы и шеи (Apr 2015)
THE FIRST EXPERIENCE WITH INGARON TREATMENT FOR CONJUNCTIVAL MELANOMA
Abstract
The paper describes the first experience with the Russian drug Ingaron from an interferon-group in the treatment of patients with conjunctival melanoma. The positive result obtained during 5-to-62-month follow-ups allows its therapeutic action to be positively appreciated.
Keywords